Revision of E2363-23 Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry
Rationale
Updated the current E2363 standard and included the glossaries of other regulatory authorities to avoid the remark that there should be only FDA glossary terms included.